Niall T. Stevens

Niall T. Stevens

Auto-generated profile, based on publicly available information

Niall T. Stevens

Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2011 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
DODeirdre O’bRien
Deirdre O’bRien
NSNiall T. Stevens
Niall T. Stevens
CLChor Hiang Lim
Chor Hiang Lim
DODonncha F. O’bRien
Donncha F. O’bRien
ESEdmond Smyth
Edmond Smyth
HHHilary Humphreys
Hilary Humphreys

15 March 2014 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
OCOrla J. Cahill
Orla J. Cahill
TCTânia Claro
Tânia Claro
NONiall O'Connor
Niall O'Connor
ACAnthony A. Cafolla
Anthony A. Cafolla
NSNiall T. Stevens
Niall T. Stevens
HHHilary Humphreys
Hilary Humphreys
The hospital environment harbors bacteria that may cause health care-associated infections. Microorganisms, such as multiresistant bacteria, can spread around the patient's inanimate environment. Some recently introduced biodecontamination approaches in hospitals have significant limitations due to the toxic nature of the gases and the length of time required for aeration. This study evaluated thein vitrouse of cold air plasma as an efficient alternative to traditional methods of biodecontamination of hospital surfaces. Cultures of methicillin-resistantStaphylococcus aureus(MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum-β-lactamase (ESBL)-producingEscherichia coli, andAcinetobacter baumanniiwere applied to different materials similar to those found in the hospital environment. Artificially contaminated sections of marmoleum, mattress, polypropylene, powder-coated mild steel, and stainless steel were then exposed to a cold air pressure plasma single jet for 30 s, 60 s, and 90 s, operating at approximately 25 W and 12 liters/min flow rate. Direct plasma exposure successfully reduced the bacterial load by log 3 for MRSA, log 2.7 for VRE, log 2 for ESBL-producingE. coli, and log 1.7 forA. baumannii. The present report confirms the efficient antibacterial activity of a cold air plasma single-jet plume on nosocomial bacterially contaminated surfaces over a short period of time and highlights its potential for routine biodecontamination in the clinical environment.

18 November 2014 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SHS. Hogan
S. Hogan
NSN.T. Stevens
N.T. Stevens
HHH. Humphreys
H. Humphreys
JOJ.P. O'GAra
J.P. O'GAra
EOE. O'NEill
E. O'NEill
Staphylococci, in particular Staphylococcus aureus and Staphylococcus epidermidis, are a leading cause of healthcareassociated infections. Patients who have a medical device inserted are at particular risk of an infection with these organisms as staphylococci possess a wide range of immune evasion mechanisms, one of which being their ability to form biofilm. Once embedded in a biofilm, bacteria are inherently more resistant to treatment with antibiotics. Despite advances in our understanding of the pathogenesis of staphylococcal biofilm formation, medical devices colonised with biofilms frequently require removal. New and novel approaches to prevent and treat biofilm infections are urgently required. In recent years, progress has been made on approaches that include antiadhesive strategies to prevent surface adhesion or production of bacterial adhesins, dissolution of already established biofilm, targeting of biofilm matrix for degradation and interference with biofilm regulation. Several obstacles need to be overcome in the further development of these and other novel anti-biofilm agents. Most notably, although in vitro investigation has progressed over recent years, the need for biofilm models to closely mimic the in vivo situation is of paramount importance followed by controlled clinical trials. In this review we highlight the issues associated with staphylococcal colonisation of medical devices and potential new treatment options for the prevention and control of these significant infections.

1 June 2017 in Journal of Hospital Infection
Verified
Journal Article
Closed access
SHS. Hogan
S. Hogan
MZM. Zapotoczna
M. Zapotoczna
NSN.T. Stevens
N.T. Stevens
HHH. Humphreys
H. Humphreys
JOJim O'Gara
Jim O'Gara
EOE. O'Neill
E. O'Neill

1 May 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
SHS. Hogan
S. Hogan
MZM. Zapotoczna
M. Zapotoczna
NSN. T. Stevens
N. T. Stevens
HHH. Humphreys
H. Humphreys
JOJim O'Gara
Jim O'Gara
EOE. O'Neill
E. O'Neill
Infection of intravascular catheters by Staphylococcus aureus is a significant risk factor within the health care setting. To treat these infections and attempt salvage of an intravascular catheter, antimicrobial lock solutions (ALSs) are being increasingly used. However, the most effective ALSs against these biofilm-mediated infections have yet to be determined, and clinical practice varies greatly. The purpose of this study was to evaluate and compare the efficacies of antibiotics and antiseptics in current clinical use against biofilms produced by reference and clinical isolates of S. aureus . Static and flow biofilm assays were developed using newly described in vivo -relevant conditions to examine the effect of each agent on S. aureus within the biofilm matrix. The antibiotics daptomycin, tigecycline, and rifampin and the antiseptics ethanol and Taurolock inactivated established S. aureus biofilms, while other commonly used antistaphylococcal antibiotics and antiseptic agents were less effective. These findings were confirmed by live/dead staining of S. aureus biofilms formed and treated within a flow cell model. The results from this study demonstrate the most effective clinically used agents and their concentrations which should be used within an ALS to treat S. aureus -mediated intravascular catheter-related infections.

1 March 2009 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
NSNiall T. Stevens
Niall T. Stevens
ISIrina Sadovskaya
Irina Sadovskaya
SJSaid Jabbouri
Said Jabbouri
TSTafiq Sattar
Tafiq Sattar
JOJim O'Gara
Jim O'Gara
Catherine GreeneCatherine Greene
Catherine Greene
Staphylococcus epidermidis is an opportunistic biofilm-forming pathogen associated with neurosurgical device-related meningitis. Expression of the polysaccharide intercellular adhesin (PIA) on its surface promotes S. epidermidis biofilm formation. Here we investigated the pro-inflammatory properties of PIA against primary and transformed human astrocytes. PIA induced IL-8 expression in a dose- and/or time-dependent manner from U373 MG cells and primary normal human astrocytes. This effect was inhibited by depletion of N-acetyl-beta-d-glucosamine polymer from the PIA preparation with Lycopersicon esculentum lectin or sodium meta-periodate. Expression of dominant-negative versions of the TLR2 and TLR4 adaptor proteins MyD88 and Mal in U373 MG cells inhibited PIA-induced IL-8 production. Blocking IL-1 had no effect. PIA failed to induce IL-8 production from HEK293 cells stably expressing TLR4. However, in U373 MG cells which express TLR2, neutralization of TLR2 impaired PIA-induced IL-8 production. In addition to IL-8, PIA also induced expression of other cytokines from U373 MG cells including IL-6 and MCP-1. These data implicate PIA as an important immunogenic component of the S. epidermidis biofilm that can regulate pro-inflammatory cytokine production from human astrocytes, in part, via TLR2.